Search results
US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
Center for Infectious Disease Research and Policy· 7 days agoAmid further declines in COVID activity, the CDC reported a steady rise in JN.1 spinoffs that have 2...
A Dutch man with lymphoma and other blood disorders was infected with the COVID-causing virus for...
Scientific American· 4 days agoWhen the Omicron strain of SARS-CoV-2, the virus that causes COVID, was surging around the world in...
Hologic (NASDAQ:HOLX) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS
ETF DAILY NEWS· 8 hours agoHologic (NASDAQ:HOLX – Get Free Report) posted its quarterly earnings data on Thursday. Hologic had a return on equity of 18.81% and a net margin of 11.78%. The company’s revenue for the quarter ...
Virologist who was first to share COVID genome is shut out of lab in China
Nature· 5 days agoZhang Yongzhen shared the genomic sequence of SARS-CoV-2 with the world, speeding the development of...
170 people 'likely exposed' to tuberculosis in Long Beach outbreak
LiveScience· 2 days agoA tuberculosis (TB) outbreak in Long Beach, California, has been declared a public health emergency...
Quiz: Can you pass our 9 question test on the latest theories of COVID-19 transmission
KTEP 88.5 El Paso· 6 days agoThe arrival of SARS-CoV-2, the virus responsible for COVID-19, brought a batch of vocabulary into...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 5 days agoWith parental consent and assent from child participants, the team enrolled 110 healthy children aged five to 12 years old into the MARkers of Vaccine Efficacy and Longevity in SARS ...
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
The Independent via Yahoo News· 5 days ago“In countries with ongoing SARS-CoV-2 transmission, the benefit of vaccination in protecting against...
A Scientist Says He Has the Evidence That We Live in a Simulation
Prevention via Yahoo News· 6 days agoThis last one is where Vopson makes a big claim: contrary to Charles Darwin’s idea that mutations...
Needham & Company LLC Reiterates Buy Rating for Hologic (NASDAQ:HOLX)
ETF DAILY NEWS· 9 hours agoHologic (NASDAQ:HOLX – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. Needham & Company LLC ...